References
- COVID-19 Weekly Epidemiological Update, <https://www.who.int/publications/m/item/weekly-epidemiological-update—24-november-2020>
- Elisabeth Mahase. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. Br Med J. 2020;368:m641.
- Shereen MA, Khan S, Kazmi A, et al. COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24:91–98. doi:https://doi.org/10.1016/j.jare.2020.03.005.
- Centers for Disease Control and Prevention. Frequently asked questions about SARS. 2005, <https://www.cdc.gov/sars/about/faq.html>
- World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV), <https://www.who.int/emergencies/mers-cov/en>.
- Review of the 2018–2019 influenza season in the northern hemisphere, <https://apps.who.int/iris/bitstream/handle/10665/326242/WER9432-en-fr.pdf?ua=1>
- Global Influenza Strategy 2019–2030. <https://www.who.int/influenza/global_influenza_strategy_2019_2030/en/>.
- Graham-Rowe D. Epidemiology: racing against the flu. Nature. 2011;480:S2–S3. doi:https://doi.org/10.1038/480S2a.
- Lam TT, Wang J, Shen Y, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013;502:241–244. doi:https://doi.org/10.1038/nature12515.
- Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020;26:1324–1326. doi:https://doi.org/10.3201/eid2606.200299.
- Miatech JL, Tarte NN, Katragadda S, et al. A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana. Respir Med Case Rep. 2020;31(101214). doi:https://doi.org/10.1016/j.rmcr.2020.101214.
- D'Abramo A, Lepore L, Palazzolo C, et al. Acute respiratory distress syndrome due to SARS-CoV-2 and influenza A co-infection in an Italian patient: mini-review of the literature. Int J Infect Dis.2020;97:236–239. doi:https://doi.org/10.1016/j.ijid.2020.06.056.
- Hashemi SA, Safamanesh S, Ghafouri M, et al. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J Med Virol. 2020. doi:https://doi.org/10.1002/jmv.26014.
- Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected With SARS-CoV-2 in Singapore. JAMA.2020;323:1488–1494. doi:https://doi.org/10.1001/jama.2020.3204.
- Lee N, Chan PK, Yu IT, et al. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J Clin Virol. 2007;40:333–337. doi:https://doi.org/10.1016/j.jcv.2007.08.015.
- Zahariadis G, Gooley TA, Ryall P, et al. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J.2006;13:17–22. doi:https://doi.org/10.1155/2006/862797.
- Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA, et al. Middle East Respiratory Syndrome Coronavirus and pulmonary tuberculosis coinfection: implications for infection control. Intervirology. 2017;60:53–55. doi:https://doi.org/10.1159/000477908.
- Alfaraj SH, Al-Tawfiq JA, Alzahrani NA, et al. The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome coronavirus. J Infect. 2017;74:521–523. doi:https://doi.org/10.1016/j.jinf.2017.02.001.
- Arabi YM, Al-Omari A, Mandourah Y, et al. Critically ill patients with the Middle East Respiratory Syndrome: A multicenter retrospective cohort study. Crit Care Med. 2017; 45:1683–1695. doi:https://doi.org/10.1097/CCM.0000000000002621.
- Zhang AJ, Lee AC, Chan JF, et al. Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters. Clin Infect Dis. 2020. doi:https://doi.org/10.1093/cid/ciaa1747.
- Yang XH, Deng W, Tong Z, et al. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med. 2007;57:450–459.
- Bao L, Deng W, Huang B, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830–833. doi:https://doi.org/10.1038/s41586-020-2312-y.
- Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020; 285:198005. doi:https://doi.org/10.1016/j.virusres.2020.198005.
- Zhao Y, Qin L, Zhang P, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5(13):e139834. doi:https://doi.org/10.1172/jci.insight.139834.
- Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123–1130. doi:https://doi.org/10.1080/22221751.2020.1770129.
- Chockalingam AK, Hamed S, Goodwin DG, et al. The effect of oseltamivir on the disease progression of lethal influenza A virus infection: plasma cytokine and miRNA responses in a mouse model. Dis Markers. 2016;9296457.
- Finlay BB, McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell. 2006;124:767–782. doi:https://doi.org/10.1016/j.cell.2006.01.034.
- Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771–5777. doi:https://doi.org/10.4049/jimmunol.180.9.5771.
- Joss A, Akdis M, Faith A, et al. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol. 2000;30:1683–1690. doi:https://doi.org/10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi:https://doi.org/10.1016/S0140-6736(20)30211-7.